This document from CHEP, University of Copenhagen, is a Health Economics Analysis Plan for the SCIENCE study (Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE).

It outlines the planned cost-effectiveness analysis, detailing the methods, data sources, and evaluation framework that will be used to assess the economic value of stem cell therapy compared to standard care for patients with ischemic heart disease who are not eligible for other treatments.